Other
Vaccine Effectiveness
0
Pipeline Programs↗
4
Active Trials↗
1
Companies Involved↗
Vaccine Effectiveness is an early-stage landscape with 0 programs across 1 company. The most active players are Pfizer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
7
clinical trials
Recruiting3 · 43%
Completed2 · 29%
Unknown status1 · 14%
Active, not recruiting1 · 14%
Clinical Trials
Trial Activity
7 trials
Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults
Recruiting·—·Phase 4·NCT06684743·690,000 enrolled
Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
Recruiting·—·N/A·NCT06029933·960,000 enrolled
Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years
Completed·—·N/A·NCT03694392·2,776,278 enrolled
Profiling Antibody Status and Vaccine Effectiveness in Post Vaccination With SARS CoV2 in Ain Shams University
Unknown status·—·Phase 2/3·NCT04885764·4,000 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)